What is Embark Veterinary?
Embark Veterinary is a pioneering genetics company focused on canine DNA testing. Its services provide detailed insights into a dog's breed, health predispositions, physical traits, and genetic relatives. Beyond individual pet owners, Embark Veterinary leverages the collected data to fuel groundbreaking research aimed at improving the health and longevity of all dogs. The company's commitment to advancing canine health through genetic science positions it as a leader in the pet-tech and veterinary research industries.
How much funding has Embark Veterinary raised?
Embark Veterinary has raised a total of $91.3M across 4 funding rounds:
Other Financing Round
$1.8M
Other Financing Round
$4.5M
Series A
$10M
Series B
$75M
Other Financing Round (2016): $1.8M with participation from Fabrice Grinda, Slow Ventures, and AGO Partners
Other Financing Round (2017): $4.5M led by Anne Wojcicki, Founder Collective, Section 32, and SV Angel
Series A (2019): $10M supported by Third Kind Venture Capital, Slow Ventures, FJ Labs, Anne Wojciciki, F-Prime Capital Partners, Section 32, and Freestyle Capital
Series B (2021): $75M featuring Third Kind Venture Capital, Slow Ventures, Freestyle, F-Prime Capital Partners, SoftBank Group, and SV Angel
Key Investors in Embark Veterinary
Third Kind Venture Capital
Third Kind Venture Capital is a venture capital firm specializing in early-stage investments, with a preference for the consumer internet, software, and financial services sectors. Founded in 2010, it is headquartered in New York City.
Freestyle
Freestyle VC is an early-stage venture capital firm known for backing numerous technology companies. They focus on supporting early-stage tech companies, often taking a lead role in seed investments, and are committed to helping their entrepreneurs achieve long-term growth.
SV Angel
SV Angel is a long-term investment firm dedicated to supporting founders in creating impactful businesses. They provide essential resources, strategic insights, and a vast network to help companies scale, emphasizing a commitment to doing the right thing and fostering a supportive community.
What's next for Embark Veterinary?
With the recent major strategic investment, Embark Veterinary is poised for accelerated growth and innovation. The substantial capital infusion is expected to bolster research and development efforts, potentially expanding the company's service offerings and deepening its scientific contributions. This funding will likely enable Embark Veterinary to further solidify its market position, enhance its research capabilities, and continue its mission to help dogs live longer, healthier lives through advanced genetic insights. The company's focus on data-driven research suggests future advancements in personalized veterinary care and disease prevention.
See full Embark Veterinary company page
